| Document Type
|
:
|
BL
|
| Record Number
|
:
|
840177
|
| Main Entry
|
:
|
Jjemba, Patrick K.
|
| Title & Author
|
:
|
Pharma-ecology : : the occurrence and fate of pharmaceuticals and personal care products in the environment /\ Patrick K. Jjemba.
|
| Edition Statement
|
:
|
Second edition.
|
| Publication Statement
|
:
|
Hoboken, NJ :: Wiley,, [2018]
|
| Page. NO
|
:
|
1 online resource
|
| ISBN
|
:
|
1119312299
|
|
|
:
|
: 1119312302
|
|
|
:
|
: 1119312329
|
|
|
:
|
: 9781119312291
|
|
|
:
|
: 9781119312307
|
|
|
:
|
: 9781119312321
|
|
|
:
|
1119312280
|
|
|
:
|
9781119312284
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Intro; Title Page; Copyright Page; Contents; Preface; Chapter 1 Usage of Pharmaceutical and Personal Care Products; 1.1 Pharmaceutical Consumption Trends; Study Questions; References; Chapter 2 Most Prescribed Pharmaceuticals and Related Endpoints; 2.1 Antihypertensive and Cardiovascular; 2.2 Anxiolytic Sedatives, Hypnotics, and Antipsychotics; 2.3 Analgesics and Anti-inflammatory Drugs; Study Questions; References; Chapter 3 Usage of Antimicrobial Agents and Related Endpoints; 3.1 Cell Wall Synthesis Inhibiting Antibiotics; 3.2 Inhibitors of Protein Synthesis.
|
|
|
:
|
3.3 Nucleic Acid Synthesis Inhibitors3.4 Antagonism to Metabolic Processes; 3.5 Antibiotics that Disrupt Membrane Integrity; 3.6 Other Antimicrobials; Study Questions; References; Chapter 4 Usage of Other Groups of Pharmaceuticals and Related Endpoints; 4.1 Gastrointestinal Drugs; 4.2 Antidiabetic Drugs; 4.3 Diuretics and Electrolytes; 4.4 Thyroid System Medication; 4.5 Respiratory Drugs; 4.6 Oral Contraceptive and Reproductive Therapeutics; 4.7 Biophosphonates and Other Skeletal Ailment Drugs; 4.8 Steroids; 4.9 Hematologic Drugs; 4.10 Nutritional Drugs; 4.11 Triptans; 4.12 Anesthetics.
|
|
|
:
|
4.13 Antineoplastics and ImmunosuppressantsStudy Questions; References; Chapter 5 Personal Care Products of Environmental Concern; 5.1 Fragrances and Musks; 5.2 Ultraviolet Light Filters; 5.3 Detergents; 5.4 Disinfectants; Study Questions; References; Chapter 6 Detection and Occurrence of PPCPs in the Environment; 6.1 Detection of PPCPs in the Environment; 6.1.1 Detection Using Instrumentation; 6.1.2 Detection Using Bioassays; 6.2 Occurrence of PPCPs in Various Environments; 6.2.1 Aquatic Systems; 6.2.1.1 PPCPs in Wastewater; 6.2.1.2 PPCPs in Surface Water; 6.2.1.3 PPCPs in Groundwater.
|
|
|
:
|
6.2.1.4 PPCPs in Potable Water6.2.2 Occurrence of PPCPs in Sediments; 6.2.3 Occurrence of PPCPs in Soil; 6.2.4 PPCPs in Aerial Environments; 6.3 Excretion as a Driver of Pharmaceutical Occurrence in the Environment; Study Questions; References; Chapter 7 Ecopharmacokinetics and Ecopharmacodynamics of PPCPs; 7.1 Overview of Pharmacokinetics and Pharmacodynamics; 7.1.1 PPCP Sorption and Bioavailability in the Environment; 7.1.2 Compound Half-life and Clearance; 7.2 Degradation of PPCPs in the Environment; 7.2.1 Degradation of Antibiotics in the Environment.
|
| Abstract
|
:
|
"Sales handles: - Links the health and environmental sciences professions' concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment - Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed - Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice - Updates information on PPCPs' ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter Bridges the gap between medicine / public health and environmental science Market description: Engineers, toxicologists, ecologists, microbiologists, chemists involved in pollution and environmental analysis. Regulatory agencies like the EPA or FDA, which are concerned with the potential negative impacts of pharmaceutical products and waste. Pharmaceutical professionals who design and develop pharmaceutical and personal care products (PPCPs) and who need to understand how they impact the environment"--
|
|
|
:
|
"This book links the health and environmental sciences professions; concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment. Knowledge about the ecological impact of PPCPs is dynamically changing as better and more sensitive detection techniques become available, and new information has come up since the book first published. This new edition brings the readership up-to-date and continues to bridge the gap between medicine / public health and environmental science. It is an approach that arouses interest in the topic among health-care providers, engineers, toxicologists, pharmacists, ecologists, microbiologists, chemists, and policy makers. Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice Updates information on PPCPs ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter"--
|
| Subject
|
:
|
Drugs-- Environmental aspects.
|
| Subject
|
:
|
Drugs-- Toxicology.
|
| Subject
|
:
|
Environmental toxicology.
|
| Subject
|
:
|
Hygiene products-- Environmental aspects.
|
| Subject
|
:
|
Hygiene products-- Toxicology.
|
| Subject
|
:
|
Drugs-- Toxicology.
|
| Subject
|
:
|
Environmental toxicology.
|
| Subject
|
:
|
SCIENCE-- Chemistry-- Organic.
|
| Subject
|
:
|
TECHNOLOGY ENGINEERING-- Environmental-- Pollution Control.
|
| Dewey Classification
|
:
|
615.9/02
|
| LC Classification
|
:
|
RA1238
|
| NLM classification
|
:
|
SCI013040TEC010010bisacsh
|